Ads
related to: breathing problems with multiple myeloma patients stories- Phase 3 Trials
See Study Results
From the Latest Trial
- Treatment Schedule
Learn How This Treatment Is Given
See the Infusion Schedule
- Safety Information
Read Safety Information
for Patients and Caregivers
- Patient Support Program
Eligible Patients May Qualify
for Financial Assistance
- Phase 3 Trials
Search results
Results From The WOW.Com Content Network
Central neurogenic hyperventilation (CNH) is an abnormal pattern of breathing characterized by deep and rapid breaths at a rate of at least 25 breaths per minute. Increasing irregularity of this respiratory rate generally is a sign that the patient will enter into coma.
Treatment of patients with this POEMS syndrome variant who have evidence of bone lesions and/or myeloma proteins are the same as those for POEMS syndrome patients. In the absence of these features, treatment with rituximab , a monoclonal antibody preparation directed against B cells bearing the CD20 antigen, or siltuximab , a monoclonal ...
This page was last edited on 12 November 2021, at 01:10 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Multiple myeloma is the second-most prevalent blood cancer (10%) after non-Hodgkin's lymphoma. [154] It represents about 1.8% of all new cancers and 2.1% of all cancer deaths. [7] Multiple myeloma affects slightly more men than women.
People who died from the plasma cell cancer multiple myeloma. Myeloma is a form of what is commonly known as "blood cancer". See: Category:People with multiple myeloma for those currently living with the disease.
The International Myeloma Foundation (IMF) is an American non-profit organization serving patients with myeloma, a cancer of plasma cells in the bone marrow.The IMF also provides support and information for family members, caregivers of myeloma patients, physicians and nurses.
Ad
related to: breathing problems with multiple myeloma patients stories